tobramycin has been researched along with Deafness in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akbergenov, R; Böttger, EC; Dubbaka, SR; Duscha, S; Lang, K; Matt, T; Meyer, M; Ng, CL; Perez-Fernandez, D; Ramakrishnan, V; Schacht, J; Sha, SH; Shcherbakov, D; Vasella, A; Xie, J | 1 |
| Lee, KS; Pollak-Christian, E | 1 |
| Blom, AM; de Hoog, M; Hoeve, LJ; van den Anker, JN; van Zanten, GA | 1 |
| Delgado, F; Guerrero, JM; Lopez-Gonzalez, MA; Osuna, C; Torronteras, R | 1 |
| Burr, S; Degg, C; Morgan, DW; Mulheran, M; Stableforth, DE | 1 |
| Hyman-Tylor, P; Knox, A; Mulheran, M; Smyth, A; Tan, KH | 1 |
7 other study(ies) available for tobramycin and Deafness
| Article | Year |
|---|---|
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Binding Sites; Deafness; Drug Design; Gentamicins; Guinea Pigs; Hair Cells, Auditory; HEK293 Cells; Humans; Mice; Mitochondria; Mutagenesis; Mycobacterium; Nebramycin; Organ Culture Techniques; Protein Biosynthesis; Pseudomonas aeruginosa; Rabbits; Reticulocytes; Ribosomes; Staphylococcus aureus | 2012 |
Importance of diagnostic work-up of Guillain-Barré syndrome in pregnancy.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Child Development; Cytomegalovirus Infections; Deafness; Exanthema; Female; Fever; Guillain-Barre Syndrome; Hepatomegaly; Humans; Infant, Newborn; Male; Neurodevelopmental Disorders; Platelet Transfusion; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome, Newborn; Splenomegaly; Thrombocytopenia; Tobramycin | 2016 |
A pilot case control follow-up study on hearing in children treated with tobramycin in the newborn period.
Topics: Acoustic Impedance Tests; Audiometry, Evoked Response; Case-Control Studies; Deafness; Ear, Middle; Evoked Potentials, Auditory, Brain Stem; Follow-Up Studies; Humans; Infant, Newborn; Otoscopes; Pilot Projects; Risk Factors; Time Factors; Tobramycin; Tympanic Membrane | 2002 |
Tobramycin for nebulisation: new formulation. A high price for a small improvement in formulation.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Clinical Trials as Topic; Cystic Fibrosis; Deafness; Drug Approval; Drug Evaluation; European Union; Humans; Pneumonia; Pseudomonas aeruginosa; Tinnitus; Tobramycin; Voice Disorders | 2002 |
Ototoxicity caused by aminoglycosides is ameliorated by melatonin without interfering with the antibiotic capacity of the drugs.
Topics: Animals; Anti-Bacterial Agents; Deafness; Escherichia coli; Female; Gentamicins; Hair Cells, Auditory, Outer; Melatonin; Microbial Sensitivity Tests; Otoacoustic Emissions, Spontaneous; Pineal Gland; Pseudomonas aeruginosa; Rats; Rats, Wistar; Tobramycin | 2000 |
Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Audiometry, Pure-Tone; Child; Cystic Fibrosis; Deafness; Drug Overdose; Drug Therapy, Combination; Drug Utilization; Gentamicins; Hearing; Humans; Radio Waves; Tobramycin | 2001 |
Lack of concordance in the use and monitoring of intravenous aminoglycosides in UK cystic fibrosis centers.
Topics: Anti-Bacterial Agents; Cystic Fibrosis; Deafness; Humans; Pseudomonas Infections; Tobramycin; United Kingdom | 2002 |